Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864532/0/en/Cerevance-Presents-at-35th-Symposium-on-Medicinal-Chemistry-in-Eastern-England.html
https://www.globenewswire.com/news-release/2024/04/02/2855950/0/en/Cerevance-to-Participate-at-the-23rd-Annual-Needham-Virtual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/03/13/2845419/0/en/Cerevance-Announces-Presentation-at-Alzheimer-s-Research-UK-Conference.html
https://www.globenewswire.com//news-release/2024/02/27/2836022/0/en/Cerevance-Announces-Presentation-at-AD-PD-2024-International-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2833671/0/en/Cerevance-to-Participate-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/15/2829962/0/en/Cerevance-Announces-Publication-of-CVN766-in-Bioorganic-Medicinal-Chemistry-Letters.html
https://www.globenewswire.com/news-release/2023/12/05/2790904/0/en/Cerevance-to-Participate-in-Fireside-Chat-at-the-2023-RBC-Capital-Markets-Healthcare-Private-Company-Virtual-Conference.html
https://www.globenewswire.com//news-release/2023/11/28/2786951/0/en/Cerevance-Announces-Presentation-at-the-34th-International-Symposium-on-ALS-MND.html
https://www.globenewswire.com//news-release/2023/11/13/2779075/0/en/Cerevance-Doses-First-Patient-in-ASCEND-Phase-2-Clinical-Study-of-CVN424-a-First-in-Class-Non-Dopaminergic-Therapy-for-the-Treatment-of-Parkinson-s-Disease.html
https://www.globenewswire.com//news-release/2023/11/07/2775225/0/en/Cerevance-Announces-Presentation-at-the-SFN-Neuroscience-2023-Annual-Meeting.html